iwCLL 2019 | The movement towards targetted therapies in CLL

Thomas Kipps

Thomas Kipps, MD, PhD, UC San Diego, Moores Cancer Center, La Jolla, CA, describes the movement towards targetted therapies in chronic lymphocytic leukemia (CLL) treatment through better understanding the disease biology. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter